Search results
Jun 11, 2024 · Kyowa Kirin Inc. has announced plans to invest up to $530 million in a new manufacturing facility in Sanford, North Carolina. The 171,700-square-foot, two-reactor facility will enhance the company’s development and production of biologic therapies for patients with rare and serious diseases.
Jun 14, 2024 · Dive Brief: Japan-based pharmaceutical company Kyowa Kirin plans to invest up to $530 million to build a new biologic therapies manufacturing facility in Sanford, North Carolina.
Jun 13, 2024 · Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin), a global specialty pharmaceutical company based in Japan, this week announced that its board of directors approved plans to invest up to $530 million to build a new, state-of-the-art manufacturing facility in Sanford, N.C.
Jun 10, 2024 · Company's first manufacturing facility in North America to accelerate production of new biologic. therapies to advance clinical pipeline. Facility to draw upon local talent, area colleges and ...
People also ask
What does Kyowa Kirin do?
Where is Kyowa Kirin based?
Does Kyowa Kirin have a North American presence?
Is Kyowa Kirin constructing a new manufacturing plant?
Jun 10, 2024 · Company's first manufacturing facility in North America to accelerate production of new biologic therapies to advance clinical pipeline. Facility to draw upon local talent, area colleges and ...
6 days ago · Kyowa Kirin, a pharmaceutical company based in Japan, will build a new biologics manufacturing facility in Sanford, North Carolina, expanding its worldwide manufacturing presence in North America. The facility will produce cutting-edge biologic therapies, such as next-generation antibodies, for the company’s upcoming clinical trials and future commercial purposes.
Jun 10, 2024 · Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin) (TSE: 4151), a global specialty pharmaceutical company based in Japan, today announced that its board of directors has...
